A Luminacin D Analog HL142 Inhibits Ovarian Tumor Growth and Metastasis by Reversing EMT and Attenuating the TGFβ and FAK Pathways is a research paper published in Journal of Cancer (2021). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R01 CA092160
NCI NIH HHS
Grant: R01 CA193609
NCI NIH HHS
Grant: R21 CA216585
National Institutes of Health
Grant: 1R21CA216585-01A1
Role of MTF1 in ovarian cancer
National Institutes of Health
Grant: 5R01CA092160-13
Anticancer Strategies Targeting the Autotaxin-LPA Receptor Axis
National Institutes of Health
Grant: 5R01CA193609-05
Selective Targeting Survivin for Cancer Therapy
FWCI
0.32
Citation Percentile
0.6%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals